|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 164-171, January 2003 Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers
Department of Biochemistry, Teikyo University School of Medicine, Tokyo, Japan
1 To whom correspondence should be addressed. e-mail: maeba{at}med.teikyo-u.ac.jp
The aims of the present study are to establish an appropriate system for assessing the oxidizability of cholesterol (CH) in phospholipid (PL) bilayers, and to explore the effect of ethanolamine plasmalogens on the oxidizability of CH with the system, through comparing with those of choline plasmalogens, phosphatidylethanolamine, and antioxidant A time course study of CH oxidation suggested a novel mechanism of BBEP for lowering the oxidizability of CH besides the action of scavenging radicals.
Abbreviations: AAPH, 2,2'-azobis (2-amidino-propane) dihydrochloride; BBEP, bovine brain ethanolamine plasmalogen (1-O-alk-1 enyl-2-acyl-sn-glycero-3-phosphoethanolamine); BHCP, bovine heart choline plasmalogen (1-O-alk-1 eny-2-acyl-sn-glycero-3-phosphocholine); CH, cholesterol; EYPE, egg yolk phosphatidylethanolamine; LUV, large unilammelar vesicle; PL, phospholipid; Toc, Supplementary key words free radicals unilamellar vesicles radical initiator antioxident phosphatidylethanolamine
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||